Helmsley 3.0: Abbreviated MRE
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study ID
- NCT06533228
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 10 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Magnetic Resonance Imaging (MRI) or Magnetic Resonance Enterography (MRE) — DIAGNOSTIC_TESTAbbreviated magnetic resonance enterography (MRE) imaging to detect active inflammation in patient's with known Crohn's Disease.
Study Details
The purpose of our study is to compare an abbreviated magnetic resonance imaging (MRI) of the bowel or magnetic resonance enterography (MRE) protocol to a conventional, standard of care MRE in children and adults with Crohn's Disease.
Key Dates
- Start date
- Sep 1, 2024
- Status verified
- Oct 2025
- Primary completion
- Feb 28, 2027
- Completion
- Feb 29, 2028
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: Crohn's Disease PatientsChildren and adults, who are scheduled for a clinical magnetic resonance enterography (MRE) to evaluate staging/ restaging of Crohn's disease, will be approached to undergo our novel abbreviated MRE. No intervention, observation only, perform MRE, and complete trade-off tolerance survey.
Primary Outcome Measure
Compare clinical MRE with research MRE [ Time Frame: 3 years ]
Central Contacts
- Tanita Dean(513) 803-0853
- Kristi Cole(513)636-9403
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | Jeff Fidler (PRINCIPAL_INVESTIGATOR) |
| NYU Langone | New York | New York | 10016 | Bari Dane (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
By condition
By research site
Related Studies
- Improving the Quality of Care for Adults With Inflammatory Bowel DiseaseEnrolling By Invitation · Dartmouth-Hitchcock Medical Center · Los Angeles, California
- Study of the Kono-S Anastomosis Versus the Side-to-side Functional End AnastomosisRecruiting · Weill Medical College of Cornell University · Boston, Massachusetts
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)PHASE3 · Recruiting · Eli Lilly and Company · San Francisco, California
- A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)PHASE3 · Recruiting · Takeda · Mobile, Alabama